MARS Bioimaging
PrivateLast Round
Series A
Jan 14, 2026
Total Funding Raised
$42.36M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MARS Bioimaging is a medical device company that develops and manufactures spectral photon-counting computed tomography (CT) scanners which produce quantitative 3D color x-ray images for pre-clinical research and clinical diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MARS Bioimaging Comparables
Compare MARS Bioimaging with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SCANCO Medical AG | 83% | |
| TriFoil Imaging | 83% | |
| Rigaku Holdings Corporation | 78% |
MARS Bioimaging Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 14, 2026 | ||||
| Grant | Nov 1, 2014 | ||||
| Seed | Feb 25, 2014 |
Key People
Founding team and executive leadership
MARS Bioimaging Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Powerhouse Ventures | Seed |
| Ministry of Business, Innovation and Employment | Grant |
| Booster Innovation Fund | Series A |
| Pacific Channel | Series A |
| Foundation for Research, Science and Technology | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 272% to 305.
- Jan 14, 2026
$15M round led by Pacific Channel.
Recent news
Latest coverage and updates
- signs_new_clientAug 4, 2026
MARS Bioimaging Limited signed new client Reform Radiology Ltd on Aug 4th '26.
MARS Bioimaging Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MARS Bioimaging's valuation, stock price, and market status.
Is MARS Bioimaging a public or private company?
MARS Bioimaging is a private company.
What is the current stock price of MARS Bioimaging?
MARS Bioimaging is a private company, so its shares have no public market price. Caplight tracks MARS Bioimaging's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MARS Bioimaging worth (valuation)?
Valuation information for MARS Bioimaging is not publicly available.
Can I buy MARS Bioimaging stock?
MARS Bioimaging shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MARS Bioimaging's last funding round?
MARS Bioimaging's most recent funding round was Series A on January 14, 2026.
Who are the main investors in MARS Bioimaging?
Key investors in MARS Bioimaging include Powerhouse Ventures, Pacific Channel.
Will MARS Bioimaging IPO soon?
No public IPO plans have been announced for MARS Bioimaging.
How can I track MARS Bioimaging secondary market activity?
Caplight tracks bids, offers, and trades in MARS Bioimaging's shares on secondary markets.